ECOR
- electroCore, Inc.
()
Overview
Company Summary
electroCore, Inc. is a healthcare technology company that specializes in providing non-invasive vagus nerve stimulation (nVNS) therapy. The company focuses on developing and commercializing innovative medical devices to address various health conditions that are associated with the dysfunction of the autonomic nervous system.
The core technology of electroCore revolves around delivering gentle electrical signals to the vagus nerve through the skin. The vagus nerve is a major cranial nerve that plays a crucial role in regulating various bodily functions, including heart rate, inflammation, respiratory functions, and other key autonomic functions.
electroCore's flagship product is the gammaCore device, which is a non-invasive neurostimulation device designed to treat certain disorders by stimulating the vagus nerve. The device is small, portable, and easy to use, making it suitable for at-home treatment.
The gammaCore device has been approved by regulatory authorities for the treatment of primary headache disorders such as cluster headache and migraine in adults. The device works by delivering a patented proprietary waveform of electrical stimulation to the vagus nerve via the patient's neck, reducing the severity and duration of cluster headache and migraine attacks.
In addition to primary headache disorders, electroCore is also exploring the potential of nVNS therapy in other areas of healthcare. They are conducting clinical trials and research to evaluate the effectiveness of vagus nerve stimulation in treating conditions like acute asthma exacerbation, post-traumatic stress disorder (PTSD), and other inflammatory disorders.
Overall, electroCore, Inc. aims to improve patient outcomes and quality of life by providing a non-invasive therapeutic option for various neurologically-mediated disorders through their innovative vagus nerve stimulation technology.